Journal article · 2026 · Open access

Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India

Pooja Bagdi

Journal of Pharmacognosy and Phytochemistry, 15(1), 427–432 · Published 1 January 2026 · DOI 10.22271/phyto.2026.v15.i1e.15756

Free PDFView at the publisherCite this paper

In brief

“Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India” is a 2026 journal article by Pooja Bagdi, published in Journal of Pharmacognosy and Phytochemistry. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at Journal of Pharmacognosy and Phytochemistry.

Citations
0
References
1
Authors
1

Abstract

Animal-based in vivo studies have traditionally played a central role in pharmaceutical research for evaluating drug safety, efficacy, and pharmacokinetic behaviour. However, ethical concerns, high costs, lengthy timelines, limited translational relevance, and increasing regulatory emphasis on the principles of Replacement, Reduction, and Refinement (3Rs) have accelerated the search for reliable alternatives. In recent years, artificial intelligence (AI) has emerged as a powerful tool capable of analysing complex biological data, modelling disease mechanisms, and predicting drug responses with improved accuracy. Advanced machine learning algorithms, deep learning networks, and data-driven computational platforms are now being integrated into drug discovery and development pipelines to minimize reliance on animal experimentation. This review critically evaluates the role of AI-based tools as potential replacements for in vivo studies in pharmaceutical research. Current applications of AI in predictive toxicology, pharmacokinetics, pharmacodynamics, virtual screening, and disease modelling are discussed along with representative case studies. Regulatory perspectives, validation challenges, data-related limitations, ethical considerations, and the Indian regulatory outlook are also addressed. The review concludes that while AI cannot yet completely replace in vivo studies, it has demonstrated substantial potential to significantly reduce animal usage, eliminate experimental cruelty, and improve decision-making when implemented within hybrid experimental frameworks. Additionally, the prospects of AI adoption in India are highlighted, reflecting its potential to transform national pharmaceutical research and innovation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bagdi, P. (2026). Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India. Journal of Pharmacognosy and Phytochemistry, 15(1), 427–432. https://doi.org/10.22271/phyto.2026.v15.i1e.15756

MLA 9

Bagdi, Pooja. “Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India.” Journal of Pharmacognosy and Phytochemistry, vol. 15, no. 1, 2026, pp. 427–432. https://doi.org/10.22271/phyto.2026.v15.i1e.15756.

Chicago

Bagdi, Pooja. 2026. “Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India.” Journal of Pharmacognosy and Phytochemistry 15 (1): 427–432. https://doi.org/10.22271/phyto.2026.v15.i1e.15756.

Harvard

Bagdi, P. (2026) ‘Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India’, Journal of Pharmacognosy and Phytochemistry, 15(1), pp. 427–432. doi:10.22271/phyto.2026.v15.i1e.15756.

IEEE

P. Bagdi, “Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India,” Journal of Pharmacognosy and Phytochemistry, vol. 15, no. 1, pp. 427–432, 2026, doi: 10.22271/phyto.2026.v15.i1e.15756.

BibTeX

@article{bagdi2026replacement,
  title     = {{Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India}},
  author    = {Bagdi, Pooja},
  journal   = {Journal of Pharmacognosy and Phytochemistry},
  year      = {2026},
  volume    = {15},
  number    = {1},
  pages     = {427--432},
  doi       = {10.22271/phyto.2026.v15.i1e.15756},
  url       = {https://doi.org/10.22271/phyto.2026.v15.i1e.15756}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Veterinary › Small Animals › Animal testing and alternatives

  • artificial intelligence
  • alternatives to animal testing
  • 3Rs
  • in vivo evaluation
  • predictive toxicology
  • pharmacokinetics
  • pharmacodynamics
  • virtual screening

Work with this paper

Most-cited papers in Veterinary

All highly cited Veterinary papers

Questions about this paper

How do I cite this paper in APA style?

Bagdi, P. (2026). Replacement of in vivo studies with artificial intelligence-based tools in pharmaceutical research: Status, challenges, and future perspectives in India. Journal of Pharmacognosy and Phytochemistry, 15(1), 427–432. https://doi.org/10.22271/phyto.2026.v15.i1e.15756

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Journal of Pharmacognosy and Phytochemistry.

Who wrote this paper?

Pooja Bagdi.

What is the DOI of this paper?

10.22271/phyto.2026.v15.i1e.15756. The permanent link is https://doi.org/10.22271/phyto.2026.v15.i1e.15756.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.